“Therapeutic potential of selective serotonin reuptake inhibitor and anti-inflammatory COX-2 inhibitors drugs for epilepsy”, RSD, vol. 11, no. 8, p. e55411831319, Jun. 2022, doi: 10.33448/rsd-v11i8.31319.